Macrophage Inflammatory Protein 1 beta protein (Active) (ab88198)
Overview
Properties
Constituents: 10% Trehalose, 1X PBS
Concentration information loading...Applications
Our Abpromise guarantee covers the use of ab88198 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Notes |
|---|---|
| SDS-PAGE | SDS-PAGE: Use at an assay dependent dilution. |
| Functional Studies | FuncS: Use at an assay dependent dilution. |
Protein info
-
Alternative names
- MIP 1 beta Secreted protein G 26ACT 2
- ACT-2ACT2AT744.1AT744.2C C motif chemokine 4C C motif chemokine 4 likeCC chemokine ligand 4CC chemokine ligand 4L1d2CC chemokine ligand 4L2CCL4CCL4_HUMANCCL4Lccl4l 1CCL4L1Chemokine (C C motif) ligand 4Chemokine (C C motif) ligand 4 like 1Chemokine (C C motif) ligand 4 like 1, telomericChemokine (C C motif) ligand 4 like 2Chemokine CC Motif Ligand 4G 26G 26 T lymphocyte secreted proteinG-26 T-lymphocyte-secreted proteinHC21LAG 1LAG-1LAG1Lymphocyte activation gene 1Lymphocyte activation gene 1 proteinMacrophage inflammatory protein 1 betaMacrophage inflammatory protein 1-betaMacrophage inflammatory protein 1b2MGC104418MGC126025MGC126026MIP-1-betaMIP-1-beta(1-69)MIP-1-beta(3-69)MIP1 betaMIP1BMIP1B1Monocyte adherence induced protein 5 alphaPAT 744Protein H400SCYA2SCYA4SCYA4LSecreted protein G26SIS gammaSIS-gammaSmall inducible cytokine A4Small inducible cytokine A4 (homologous to mouse Mip 1b)Small-inducible cytokine A4T cell activation protein 2T-cell activation protein 2
see all
modificationsN-terminal processed form MIP-1-beta(3-69) is produced by proteolytic cleavage after secretion from peripheral blood lymphocytes.
Target information above from: UniProt accession
P13236
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010)
.
References for Macrophage Inflammatory Protein 1 beta protein (Active) (ab88198)
ab88198 has not yet been referenced specifically in any publications.